Advancing pharmacoequity globally: reflections from the ASCPT development, regulatory, and outcomes network

Jayachandran, P.; Ladumor, M.K.; Vlasakakis, G.; Riselli, A.; Ilic, K.V.; Wijk, R.C. van; ... ; Zhang, T. (2026)

Article / Letter to editor

ASCPT has a mission to advance clinical pharmacology and translational sciences to reduce health disparities. The development, regulatory, and outcomes (DRO) network within ASCPT strives to advance pharmacoequity globally. Pharmacoequity, coined by Utibe Essien (2021), is the principle that all individuals, regardless of race, ethnicity, geography, or socioeconomic status, should have access to high-quality and evidence-based therapies. This perspective spotlights the network's contributions toward this goal and identifies priority areas to build equitable health outcomes.

• All authors: Jayachandran, P.; Ladumor, M.K.; Vlasakakis, G.; Riselli, A.; Ilic, K.V.; Wijk, R.C. van; Elmeliegy, M.; Mukker, J.K.; Sawant‐Basak, A,; Long, T.; Dong, J.; Rayad, N.; Zhang, T.
• Date: 2026-02-13
• Journal: Clinical Pharmacology & Therapeutics
• Advanced Publication: Yes
• DOI: doi:10.1002/cpt.70237
• Link: https://ascpt.onlinelibrary.wiley.com/doi/10.1002/cpt.70237